Guo Chang-Bin, Li Song
Institute of Pharmacology & Toxicology, Academy of Military Medical Sciences, Beijing 100850, China.
Yao Xue Xue Bao. 2007 Mar;42(3):231-5.
Several new drug targets of anti-atherosclerosis, emerging in the recent years, such as PPAR agonists, cholesteryl ester transfer protein (CETP) inhibitors, infusion of apolipoprotein A-I (apoA-I), liver X receptor (LXR) activators and phospholipid transfer protein (PLTP) inhibitors etc were reviewed.
近年来出现的几种抗动脉粥样硬化新药靶点，如过氧化物酶体增殖物激活受体（PPAR）激动剂、胆固醇酯转运蛋白（CETP）抑制剂、载脂蛋白A-I（apoA-I）输注、肝脏X受体（LXR）激活剂和磷脂转运蛋白（PLTP）抑制剂等，已被综述。
